Speaker

Alejandro Amador

Vice President of R&D and Operations, Navega Therapeutics

Alejandro Amador, Vice President of R&D and Operations at Navega Therapeutics, spoke at Ion Channel-Targeted Drug Development Summit (Boston, United States of America, 23–24 Sept 2026) in the session “Targeting Ion Channel Expression Through Epigenetic Gene Editing to Improve Specificity & Durability”.

Conferences: 1
Keynotes: 0
Upcoming: 0

Pharmacy & Pharmaceutical Sciences

Past appearances

Ion Channel-Targeted Drug Development Summit
23–24 Sept 2026Boston, United States of America
- SpeakerTargeting Ion Channel Expression Through Epigenetic Gene Editing to Improve Specificity & Durability
- PanelPanel: Comparing Modality Selection Decisions to Match Biology & Indication RequirementsWith Stefan McDonough, Fabricio Simao, Edward Humphries, Alexei Pushechnikov

More speakers at Ion Channel-Targeted Drug Development Summit

Christopher Ahern
Professor - Molecular Physiology & Biophysics, The University of Iowa
Bruce Bean
Professor of Neurobiology, Harvard Medical School
Gulayse Dunn
Senior Principal Scientist, Novartis
Dan Elbaum
Chief Scientific Officer, QurAlis Corp.
Jim Ellis
Chief Scientific Officer, Nocion Therapeutics, Inc.
Kelly Gatfield
Group Leader & Scientific Leader, GlaxoSmithKline

See all 16 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Alejandro Amador, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].